Calico
Our mission is said simply, yet it is quite ambitious. Calico is working to better understand the biology of aging and using those insights to advance foundational discoveries into potential medicines that enable people to lead longer and healthier lives.
Présentation
A Unique Design: Calico is officially founded with long-term funding from Alphabet, established to combine the best of academia and biotechnology without the traditional constraints of either. Operations begin in South San Francisco with a founding team of industry and academic pioneers.
Foundational Research: Calico marks its first scientific publication in PNAS, titled “Extrachromosomal circular DNA is common in yeast”.
Volume of Science: Surpassed 100 peer-reviewed scientific publications, validating the depth of Calico’s investigator-led research.
Strategic Alliances: Announced major partnerships with AbbVie and the Broad Institute of MIT and Harvard to accelerate drug discovery and genetic research.
Aging is the greatest risk factor for the world’s most common health problems, yet understanding its biology remains limited by its immense complexity. ...
Informations pratiques
- Informations mises à jour le
Fiche découverte par PHPBB Lab Bot. Page source — mar. 22 sept. 2026 06:45